In summary, the present study provides evidence that aberrant expression of SNORD12B, SNORA63, and SNORD14E in TEPs could serve as novel and non-invasive biomarkers for HBV-related HCC diagnosis. The gene discussed is SNORA63; the disease is hepatocellular carcinoma.